StarryGene Initiates Phase II Study of XMVA09 for Wet AMD Treatment
Hefei-based gene therapy biotech StarryGene announced the initiation of a Phase II clinical study for...
StarryGene
StarryGene Initiates Phase I Clinical Trial for XMVA09 Gene Therapy in wAMD
StarryGene, a biotech company specializing in gene therapy and based in Hefei, China, has announced...